Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB

NCT04520022 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Recessive Dystrophic Epidermolysis Bullosa

Interventions

DRUG: Human Umbilical Cord Blood-derived Mesenchymal Stem Cells

Sponsor

Gangnam Severance Hospital

Collaborators

[object Object]